Please use this identifier to cite or link to this item:

TitleHER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
Author(s)Martinho, Olga
Silva-Oliveira, Renato
Barbosa, Ana Margarida Martins
Granja, Sara Costa
Miranda-Gonçalves, Vera
Cardoso-Carneiro, Diana
Paula, Flávia E. de
Baltazar, Fátima
Longatto, Adhemar
Reis, R. M.
et. al.
Cervical cancer
Targeted therapy
Issue date24-Jan-2017
PublisherIvyspring International Publisher
CitationMartinho, O., Silva-Oliveira, R., Cury, F. P., Barbosa, A. M., Granja, S., Evangelista, A. F., ... & Zanon, M. (2017). HER family receptors are important theranostic biomarkers for cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors. Theranostics, 7(3), 717
Abstract(s)Persistent HPV infection alone is not sufficient for cervical cancer development, which requires additional molecular alterations for tumor progression and metastasis ultimately leading to a lethal disease. In this study, we performed a comprehensive analysis of HER family receptor alterations in cervical adenocarcinoma. We detected overexpression of HER protein, mainly HER2, which was an independent prognostic marker for these patients. By using in vitro and in vivo approaches, we provided evidence that HER inhibitors, allitinib and lapatinib, were effective in reducing cervical cancer aggressiveness. Furthermore, combination of these drugs with glucose uptake blockers could overcome the putative HIF1-a-mediated resistance to HER-targeted therapies. Thus, we propose that the use of HER inhibitors in association with glycolysis blockers can be a potentially effective treatment option for HER-positive cervical cancer patients.
Publisher version
AccessOpen access
Appears in Collections:ICVS - Artigos em revistas internacionais / Papers in international journals

Files in This Item:
File Description SizeFormat 
46.pdf2,51 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID